Danny J. M. van Galen

Danny J. M. van Galen

Auto-generated profile, based on publicly available information

Danny J. M. van Galen

Vascularization Lab, Department of Biomechanical Engineering, Technical Medical Center, Faculty of Engineering Technology, University of Twente, Enschede, The Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2025 in ASAIO Journal
Verified
Journal Article
Open access
DGDanny J. M. van Galen
Danny J. M. van Galen
ACAna Martins Costa
Ana Martins Costa
FSFranziska Siche-Pantel
Franziska Siche-Pantel
RKRuth Kemper
Ruth Kemper
NRNiels Collaborators Rochow
Niels Collaborators Rochow
SEStefan Eckstein
Stefan Eckstein
Preterm birth remains the leading cause of mortality among neonates. Despite improvements in neonatal intensive care over the years, current treatments for lung and kidney failure are highly invasive, associated with lifelong disability, and limit family integration. Artificial womb and artificial placenta technologies offer a promising alternative by providing more tailored and less invasive neonatal care. Although these technologies share some similarities, artificial womb and artificial placenta technologies differ significantly in terms of treatment initiation, treatment environment, and the potential to support family-centered care. Moreover, even though acute kidney injury is common in neonatal extracorporeal membrane oxygenation (ECMO) patients, current artificial placenta and artificial womb devices lack renal support functionality. Most artificial womb and artificial placenta studies focus on the technical feasibility of these technologies based on in-vivo animal tests. However, translation toward envisioned use of these devices in preterm neonates remains mostly underexposed. A comprehensive stakeholder analysis, including parents and caregivers, is critical to the development of socially acceptable artificial placenta and artificial womb systems. This state-of-the-art review provides an overview of conventional neonatal lung and kidney treatments, delineates the differences between artificial womb and placenta technologies, and addresses the technological and ethical challenges in advancing these technologies toward potential clinical implementation.

20 February 2024 in ASAIO Journal
Verified
Journal Article
Open access
DGDanny J. M. van Galen
Danny J. M. van Galen
QMQuint Meinders
Quint Meinders
Frank R. HalfwerkFrank R. Halfwerk
Frank R. Halfwerk
Jutta ArensJutta Arens
Jutta Arens
Extracorporeal membrane oxygenation (ECMO) is a temporary lifesaving treatment for critically ill patients with severe respiratory or cardiac failure. Studies demonstrated the feasibility of in-hospital mobilizing during and after ECMO treatment preventing neuromuscular weakness and impaired physical functioning. Despite more compact mobile ECMO devices, implementation of ambulatory ECMO remains labor-intensive, complex, and challenging. It requires a large multidisciplinary team to carry equipment, monitor and physically support the patient, and to provide a back-up wheelchair in case of fatigue. Moreover, there is no adequate solution to ensure the stability of the patient’s cannula and circuit management during ambulation. We developed a system contributing to improvement and innovation of current ambulatory ECMO patient programs. Our modular cart-in-cart system carries necessary ECMO equipment, features an extendable walking frame, and contains a folding seat for patient transport. An adjustable shoulder brace with lockable tubing-connectors enables safe fixation of the blood tubing. ECMOve provides safety, support, and accessibility while performing ambulatory ECMO for both patient and caregiver. Prototype evaluation in a simulated intensive care unit showed feasibility of our design, but needs to be evaluated in clinical care. Export

6 May 2024 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
PPPrasanna Padmanaban
Prasanna Padmanaban
DGDanny van Galen
Danny van Galen
NSNasim Salehi-Nik
Nasim Salehi-Nik
MZMariia Zakharova
Mariia Zakharova
LSLoes Segerink
Loes Segerink
JRJeroen Rouwkema
Jeroen Rouwkema
Not only the flow of liquid through vasculature, but also external fluid flows can affect the organization and maturation of vessels.

14 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
PPPrasanna Padmanaban
Prasanna Padmanaban
DGDanny van Galen
Danny van Galen
NSNasim Salehi-Nik
Nasim Salehi-Nik
MZMariia Zakharova
Mariia Zakharova
LSLoes Segerink
Loes Segerink
JRJeroen Rouwkema
Jeroen Rouwkema
The impact of fluid flow shear stresses, generated by the movement of blood through vasculature, on the organization and maturation of vessels is widely recognized. Nevertheless, it remains uncertain whether external fluid flows outside of the vasculature in the surrounding tissue can similarly play a role in governing these processes. In this research, we introduce an innovative technique called superfusion-induced vascular steering (SIVS). SIVS involves the controlled imposition of external fluid flow patterns onto the vascularized chick chorioallantoic membrane (CAM), allowing us to observe how this impacts the organization of vascular networks. To investigate the concept of SIVS, we conducted superfusion experiments on the intact chick CAM cultured within engineered eggshell system, using phosphate buffered saline (PBS). To capture and analyze the effects of superfusion, we employed a custom-built microscopy setup, enabling us to image both superfused and non-superfused regions within the developing CAM. This study provides valuable insights into the practical application of fluid superfusion within an in vivo context, shedding light on its significance for understanding tissue development and manipulation in an engineering setting.